Luminex Corporation First Quarter Earnings Release Scheduled for May 7, 2009
April 23 2009 - 10:00AM
Business Wire
Luminex Corporation (NASDAQ:LMNX) today announced that
it�expects to report first quarter results on Thursday, May 7,
2009. Results are scheduled for release after the close of
trading.
Management will hold a conference call to discuss the operating
highlights and financial�results for the first quarter ended March
31, 2009, on May 7, 2009, at 5:00�p.m. Eastern time.
The conference call will be webcast live and will be accompanied
by a slide presentation, both of which may be accessed at Luminex
Corporation's website at http://www.luminexcorp.com. Simply log on
to the web at the address above, go to the Company section and
access the Investor Relations link. Please go to the website at
least 15 minutes prior to the call to register, download and
install any necessary audio/video software. If you are unable to
participate during the live webcast, the call and slides will be
archived for six months on the website using the 'replay' link.
The use of pop-up blocking software may impair your ability to
view webcasts. If you use this software, press and hold the CTRL
key when you click on the Register button. Please contact your IT
group if you are unable to override this feature. Unauthorized
recording or downloading of this event is not permitted.
About Luminex Corporation
Luminex Corporation develops, manufactures and markets
proprietary biological testing technologies with applications
throughout the diagnostic and life sciences industries. The
Company's xMAP� multiplex solutions include an open-architecture,
multi-analyte technology platform that delivers fast, accurate and
cost-effective bioassay results to markets as diverse as
pharmaceutical drug discovery, clinical diagnostics and biomedical
research, including the genomics and proteomics research markets.
The Company's xMAP technology is sold worldwide and is already in
use in leading clinical laboratories as well as major
pharmaceutical, diagnostic and biotechnology companies. Further
information on Luminex Corporation or xMAP technology can be
obtained at www.luminexcorp.com.
Statements made in this release that express Luminex's or
management's intentions, plans, beliefs, expectations or
predictions of future events are forward-looking statements. The
words "believe," "expect," "intend," "estimate," "anticipate,"
"will," "could," "should" and similar expressions are intended to
further identify such forward-looking statements for purposes of
the Private Securities Litigation Reform Act of 1995. It is
important to note that the Company's actual results or performance
could differ materially from those anticipated or projected in such
forward-looking statements. Factors that could cause Luminex's
actual results or performance to differ materially include risks
and uncertainties relating to, among others, market demand and
acceptance of Luminex's products, the Company's dependence on
strategic partners for development, commercialization and
distribution of products, concentration of the Company's revenue in
a limited number of strategic partners, fluctuations in quarterly
results due to a lengthy and unpredictable sales cycle and bulk
purchases of consumables, Luminex's ability to scale manufacturing
operations and manage operating expenses, gross margins and
inventory levels, potential shortages of components, competition,
the timing of regulatory approvals, the implementation, including
any modification, of the Company's strategic operating plans, risks
and uncertainties associated with implementing our acquisition
strategy and the ability to integrate acquired companies or
selected assets into our consolidated business operations, as well
as the risks discussed under the heading "Risk Factors" in
Luminex's Reports on Forms 10-K and 10-Q, as filed with the
Securities and Exchange Commission. The forward-looking statements
contained herein represent the judgment of Luminex as of the date
of this press release, and Luminex expressly disclaims any intent,
obligation or undertaking to release publicly any updates or
revisions to any forward-looking statements to reflect any change
in Luminex's expectations with regard thereto or any change in
events, conditions or circumstances on which any such statements
are based.
Luminex (NASDAQ:LMNX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Luminex (NASDAQ:LMNX)
Historical Stock Chart
From Jul 2023 to Jul 2024